SCHEMBL8395149

SCHEMBL8395149

CS(=O)(=O)c1ncc(C(=O)c2ccccc2)c(C(F)(F)F)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JUN P05412 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
HTT P42858 2/20 0.43
HSD17B10 Q99714 2/20 0.43
XPO1 O14980 1/20 0.41
KMT2A Q03164 2/20 0.40
RORC P51449 1/20 0.39
SDHB P21912 3/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
S1PR4 O95977 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8396850 0.78 XPO1 (0.65) JUNNFKB1NFKB2RELANR1H2
SCHEMBL10555889 0.75 SDHB (0.49) PTGS1PTGS2HTTHSD17B10KMT2A
SCHEMBL8398384 0.75 JUN (0.59) JUNNFKB1NFKB2RELANR1H2
SCHEMBL30106723 0.68 GAA (0.51) JUNNFKB1NFKB2RELAHTT
SCHEMBL6016298 0.68 MEN1 (0.47) KMT2AHPGDMEN1LMNAPOLB
SCHEMBL29076982 0.68 GAA (0.51) JUNNFKB1NFKB2RELAHTT
SCHEMBL14004179 0.68 NPC1 (0.47) PTGS1PTGS2HTTKMT2ARORC
SCHEMBL14643154 0.67 SDHB (0.49) NR1H2NR1H3PTGS1PTGS2HTT
SCHEMBL6336114 0.66 PTGS2 (0.47) PTGS1PTGS2
SCHEMBL6016592 0.66 NPC1 (0.45) PTGS2HTTHPGDPOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935966-A COMPOUNDS THAT BLOCK THE ACTIVATION OF TRANSCRIPTION FACTORS THROUGH INHIBITION OF A FAMILY OF SPECIFIC KINASES, DECREASING PROINFLAMMATORY PROTEINS TO TREAT AUTOIMMUNE DISEASES AND AS GENERAL ANTIINFLAMMATORY AGENTS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-10 US disclosed
WO-1998038171-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-03 WO disclosed
WO-1997009325-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1997-03-13 WO disclosed